Imaging of cardiovascular complications and features in COVID-19
TTE | MRI | CT |
---|---|---|
RV dilatationa | Nonischemic injury (T1-based) 1. Abnormal T1 mapping 2. Increase extracellular volume quantification 3. Late gadolinium enhancement subepicardial midwall, patchy or scattered distribution of LGE | Pericardial effusion |
Left ventricular contractile dysfunction | Myocardial edema (T2-based) 1. Abnormal T2 mapping 2. Abnormal T2- weighted imaging | Epicardial fat thickness |
Left ventricular diastolic dysfunction | Global or regional abnormality systolic function (cine) | CTPAb |
Pericardial effusion Decreased GLS | Pericardial effusion | CAC detectionc |
a RV dilatation and dysfunction as the most common echocardiographic abnormalities with prognostic significance in most patients resolve after a period of acute infection. b CTPA is the principal method that confirms PE. c Additional CAC detection, although not routinely performed, maybe a relatively available marker of worse prognosis in patients with COVID-19